Circulation:巨噬细胞的Dicer通过调节线粒体氧化代谢抵制动脉粥样硬化

2018-11-03 MedSci MedSci原创

依赖线粒体氧化代谢的巨噬细胞激活在炎症和预防动脉粥样硬化中发挥核心作用。在动脉粥样硬化过程中,巨噬细胞需处理大量来自被吞噬的修饰的脂蛋白的胆固醇和甘油三酯。虽有多种microRNAs调控巨噬细胞极化,但在动脉粥样硬化过程中,microRNA生成酶Dicer在巨噬细胞激活中的作用尚不明确。为评估Dicer在动脉粥样硬化中的作用,研究人员采用高脂膳食饲养有/无特异性敲除巨噬细胞Dicer的Apoe-/

依赖线粒体氧化代谢的巨噬细胞激活在炎症和预防动脉粥样硬化中发挥核心作用。在动脉粥样硬化过程中,巨噬细胞需处理大量来自被吞噬的修饰的脂蛋白的胆固醇和甘油三酯。虽有多种microRNAs调控巨噬细胞极化,但在动脉粥样硬化过程中,microRNA生成酶Dicer在巨噬细胞激活中的作用尚不明确。

为评估Dicer在动脉粥样硬化中的作用,研究人员采用高脂膳食饲养有/无特异性敲除巨噬细胞Dicer的Apoe-/-小鼠12周。然后对小鼠进行抗-argonaute 2 RNA原位杂交和RNA深度测序,鉴定调节Dicer表型效应的microRNA和mRNA靶点。

结果发现,敲除巨噬细胞的Dicer会加速小鼠的动脉粥样硬化,伴随炎症反应增强、病损处巨噬细胞内的脂质积累增多。在体外,由于线粒体脂肪酸氧化代谢受损,Dicer缺陷型巨噬细胞内的替代激活受限,充满脂质的泡沫细胞形成加快。恢复miR-10a、let-7b和miR-195a的表达可恢复激活改变的Dicer缺陷型巨噬细胞的氧化代谢。用miR-10a抑制配体依赖性核受体辅抑制因子,可促进脂肪酸氧化(介导Dicer的脂解和抗炎作用)。miR-10a的表达与人类动脉粥样硬化的进展呈负相关。采用靶位点阻滞剂封闭配体依赖性核受体辅抑制因子和miR-10a之间的相互作用可加剧小鼠的动脉粥样硬化进展。

Dicer通过增强以脂肪酸为燃料的线粒体呼吸,协调调节巨噬细胞的炎症反应和脂质代谢,从而发挥抗动脉粥样硬化的作用;提示促进巨噬细胞Dicer/miR-10a依赖性的代谢重编程或可应用于预防动脉粥样硬化。


原始出处:

Yuanyuan Wei,et al. Dicer in Macrophages Prevents Atherosclerosis by Promoting Mitochondrial Oxidative Metabolism. 24 Jul 2018. Circulation. 2018;138:2007–2020

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1944566, encodeId=f9d7194456697, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Thu Feb 28 12:57:00 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804755, encodeId=f1f41804e55b5, content=<a href='/topic/show?id=7bd9e760006' target=_blank style='color:#2F92EE;'>#线粒体氧化代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77600, encryptionId=7bd9e760006, topicName=线粒体氧化代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Tue Sep 10 06:57:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997052, encodeId=f6ea199e052f8, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9347, encryptionId=f97d934e3c, topicName=ICER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Dec 26 10:57:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858910, encodeId=979918589100e, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sat Nov 17 06:57:00 CST 2018, time=2018-11-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1944566, encodeId=f9d7194456697, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Thu Feb 28 12:57:00 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804755, encodeId=f1f41804e55b5, content=<a href='/topic/show?id=7bd9e760006' target=_blank style='color:#2F92EE;'>#线粒体氧化代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77600, encryptionId=7bd9e760006, topicName=线粒体氧化代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Tue Sep 10 06:57:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997052, encodeId=f6ea199e052f8, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9347, encryptionId=f97d934e3c, topicName=ICER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Dec 26 10:57:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858910, encodeId=979918589100e, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sat Nov 17 06:57:00 CST 2018, time=2018-11-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1944566, encodeId=f9d7194456697, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Thu Feb 28 12:57:00 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804755, encodeId=f1f41804e55b5, content=<a href='/topic/show?id=7bd9e760006' target=_blank style='color:#2F92EE;'>#线粒体氧化代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77600, encryptionId=7bd9e760006, topicName=线粒体氧化代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Tue Sep 10 06:57:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997052, encodeId=f6ea199e052f8, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9347, encryptionId=f97d934e3c, topicName=ICER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Dec 26 10:57:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858910, encodeId=979918589100e, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sat Nov 17 06:57:00 CST 2018, time=2018-11-17, status=1, ipAttribution=)]
    2018-12-26 chenwq08
  4. [GetPortalCommentsPageByObjectIdResponse(id=1944566, encodeId=f9d7194456697, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Thu Feb 28 12:57:00 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804755, encodeId=f1f41804e55b5, content=<a href='/topic/show?id=7bd9e760006' target=_blank style='color:#2F92EE;'>#线粒体氧化代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77600, encryptionId=7bd9e760006, topicName=线粒体氧化代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0357291, createdName=xiaoshitou, createdTime=Tue Sep 10 06:57:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997052, encodeId=f6ea199e052f8, content=<a href='/topic/show?id=f97d934e3c' target=_blank style='color:#2F92EE;'>#ICER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9347, encryptionId=f97d934e3c, topicName=ICER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Dec 26 10:57:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858910, encodeId=979918589100e, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Sat Nov 17 06:57:00 CST 2018, time=2018-11-17, status=1, ipAttribution=)]
    2018-11-17 jeanqiuqiu

相关资讯

Circulation:蛋白酶激活受体-2参与血管炎症和动脉粥样硬化的发生

凝血系统与血管炎症密切相关,但其机制尚不明确。近期有研究表明蛋白酶激活受体(PAR)-2是激活因子X的主要受体,在血管细胞和白细胞中均有表达,提示PAR-2可能参与炎症病理过程。现研究人员对PAR-2在血管炎症和动脉粥样硬化形成中的作用进行研究。研究人员建立了一种缺乏系统PAR-2表达的脂蛋白E缺陷的小鼠(PAR-2-/-ApoE-/-)。还通过骨髓移植建立ApoE-/- 小鼠,缺乏或仅在骨髓(B

J Clin Invest:研究发现乙醛脱氢酶2调控动脉粥样硬化的新机制

心血管疾病是目前全球死亡率最高的疾病,动脉粥样硬化是其发病和死亡的主要病因。在动脉粥样硬化发生发展的过程中,巨噬细胞主要通过摄取氧化修饰的低密度脂蛋白(oxLDL),形成泡沫细胞沉积在血管内膜从而促进动脉粥样斑块的形成。

Diabetic Med:糖尿病老年人中抑郁症状的患病率和相关性:社区动脉粥样硬化风险(ARIC)研究

近日,国际杂志 《Diabetic Med》上在线发表一项关于糖尿病老年人中抑郁症状的患病率和相关性:社区动脉粥样硬化风险(ARIC)研究。研究目的是记录老年人血糖谱中当前抑郁症状和抑郁史的患病率,并检查健康状况和医疗保健满意度,获取和利用的衡量标准是否可解释糖尿病状态下当前抑郁症状患病率的差异。 研究人员对参加2011 - 2013年动脉粥样硬化社区风险(ARIC)研究的6226名67-9

JACC:血脂促进动脉粥样硬化观点-强调LDL-C累积暴露,终生最适LDL-C或为70~80 mg/dl

近期,JACC杂志阐述了血脂对心血管健康的影响,并提出总动脉粥样硬化负荷这一新指标用于评估终生心血管事件风险,并表示应该重新定义一级预防以及重置最佳血脂目标值。提出总动脉粥样硬化负荷新指标:LDL-C水平×累积暴露时间文章指出,LDL-C与心血管疾病风险的因果关系取决于LDL-C水平和累积暴露时间。年龄乘以LDL-C水平可以计算出总动脉粥样硬化负荷(如图1),这是影响终生心血管事件的关键指标。

Circulation:ERV1/ChemR23信号可通过调节巨噬细胞氧化低密度脂蛋白的摄取和吞噬作用来预防动脉粥样硬化

血管炎症消退能力受损,除了会增强促炎信号,还在动脉粥样硬化中发挥重要作用。通过12/15脂氧合酶通路形成的促溶性脂质介质对小鼠动脉粥样硬化具有保护作用。n-3多不饱和脂肪酸,包括二十碳五烯酸(EPA),作为脂质介质形成的底物,可通过其同源G-蛋白偶联受体转化其潜在的抗炎和促溶作用。现研究人员对调节动脉粥样硬化疾病进展的EPA补充和脂质介质形成相关的信号通路进行研究。给Apoe-/-小鼠补充EPA后

Circulation:在缺失CETP的情况下,ADCY9失活可抵抗动脉粥样硬化

药物基因组学研究表明ADCY9基因型决定了CETP(胆甾醇酯转移蛋白)抑制剂达塞曲匹对心血管事件和动脉粥样硬化成像的影响。ADCY9和CETP活性相互作用的潜在机制尚未明确。研究人员采用进行或不进行CETP基因改造(CETPtgAdcy9Gt/Gt和CETPtgAdcy9WT)的Adcy9失活型(Adcy9Gt/Gt)和野生型(WT)小鼠进行动脉粥样硬化试验,予以注射表达功能获得性突变PCSK9(